Dental Implant Therapy on a Patient With von Willebrand Disease: A Case Study

被引:7
作者
Kang, Michael [1 ]
Kang, Philip [1 ]
机构
[1] Columbia Univ, Coll Dent Med, Sect Oral Diagnost & Rehabil Sci, Div Periodont, PH7E 124,630 W 168 St, New York, NY 10032 USA
关键词
anticoagulants; hemostasis; oral surgery; periodontal surgery; SURGERY;
D O I
10.1097/ID.0000000000000821
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Von Willebrand disease (vWD) is the most common hereditary disorder affecting coagulation. Patients with this disorder are at a higher risk of postoperative complications after dental surgery. This article discusses the successful treatment for a patient with vWD undergoing implant therapy. Case Description: A young 21-year-old patient with vWD lost tooth #30 because of caries and required implant therapy. Through collaboration with a hematologist administering prophylactic desmopressin (DDAVP), the implant surgery was performed without any postoperative complications. The implant successfully integrated and was restored into function. The successful outcome met expectations after careful planning and execution. Practical Implications: Collaboration with the appropriate medical providers, as well as treatment modifications for surgical procedures during implant therapy, is necessary for successful treatment of a patient with von Willebrand disorder.
引用
收藏
页码:599 / 601
页数:3
相关论文
共 50 条
[11]   Replacement Therapy in Patients with Von Willebrand Disease-Indications and Monitoring [J].
Nowak-Goettl, Ulrike ;
Miesbach, Wolfgang ;
Koscielny, Juergen ;
Dempfle, Carl-Erik ;
Maegele, Marc ;
Prondzinski, Mario von Depka ;
Westrup, Dagmar ;
Spannagl, Michael .
HAMOSTASEOLOGIE, 2019, 39 (04) :326-338
[12]   Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease [J].
Batlle, Javier ;
Fernanda Lopez-Fernandez, Maria ;
Loures Fraga, Esther ;
Rodriguez Trillo, Angela ;
Almudena Perez-Rodriguez, Maria .
BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) :89-100
[13]   Dental Implant Placement in a Patient With Polycythemia Vera: A Case Report [J].
Wang, Xiaona ;
Meng, Xing .
JOURNAL OF ORAL IMPLANTOLOGY, 2024, 50 (06) :584-588
[14]   Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia [J].
Wang, Zhihong J. ;
Onwuzurike, Nkechi ;
Callaghan, Michael U. ;
Rajpurkar, Madhvi ;
Chitlur, Meera ;
Lusher, Jeanne M. .
PEDIATRIC BLOOD & CANCER, 2008, 51 (03) :416-418
[15]   Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease [J].
Friederich, PW ;
Wever, PC ;
Briët, E ;
Doorenbos, CJ ;
Levi, M .
AMERICAN JOURNAL OF HEMATOLOGY, 2001, 66 (04) :292-294
[16]   Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease [J].
De Meyer, Simon F. ;
Vandeputte, Nele ;
Pareyn, Inge ;
Petrus, Inge ;
Lenting, Peter J. ;
Chuah, Marinee K. L. ;
VandenDriessche, Thierry ;
Deckmyn, Hans ;
Vanhoorelbeke, Karen .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (09) :1621-1626
[17]   Anaesthesia recommendations for Von Willebrand disease [J].
Bonhomme, Vincent ;
Defresne, Aline ;
Maquoi, Isablle ;
Minon, Jean-Marc .
ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2019, 60 :S119-S129
[18]   Fibrinolysis and von Willebrand factor in Alzheimer's disease and vascular dementia - a case-referent study [J].
Hagnelius, Nils-Olof ;
Boman, Kurt ;
Nilsson, Torbjorn K. .
THROMBOSIS RESEARCH, 2010, 126 (01) :35-38
[19]   New concepts in Von Willebrand disease [J].
Sadler, JE .
ANNUAL REVIEW OF MEDICINE, 2005, 56 :173-+
[20]   Von Willebrand disease in the emergency department [J].
Livesey, K. ;
Yealy, D. M. ;
Li, J. ;
Moore, C. G. ;
Ragni, M. V. .
HAEMOPHILIA, 2016, 22 (02) :263-267